
MaioRegen Prime for the treatment of osteochondral lesions with severely compromised subchondral bone

MaioRegen is a multi-layered matrix, manufactured through a patented process.
The product, composed by collagen and hydroxyapatite enriched with magnesium, mimics the chondral and osteochondral tissues, both in the chemical composition and in the micro- and nano-structure.
Cartilage layer
Calcified cartilage and sub-chondral bone layer
Spongy bone layer
A) The damaged tissue is removed to create ab suitable lodging to host the implant and guarantee an adequate blood flow from the subchondral bone
B) Maioregen fits perfectly into lesion site, restoring anatomic continuity
C) The biomimetic porous structure and the chimical composition favour cellular migration. The bone marrow-derived cells selectively adhere to the collagen fibres, colonizing the entire scaffold
D) Cells proliferate, differentiate and synthesize matrix according to scaffold layer composition. The progressive resorption of MaioRegen and the simultaneous cell mediated remodeling favour the complete regeneration of the tissue

(tri-layer) is indicated for the treatment of single/multiple osteochondral lesions with severely compromised bone, Outerbridge Grade IV. Lesions can be f traumatic, post-traumatic or degenerative origin, as well as caused by osteochondritis dissecans (OCD).

| Code | Description | |
|---|---|---|
| 01600288 | 2,0×3,0x0,6 cm | 1 |
| 01600286 | 3,0×4,0x0,6 cm | 1 |
| 01600285 | Ø = 1,2 cm H = 0,6 cm | 1 |
| 01600275 | Ø = 1,5 cm H = 0,6 cm | 1 |
| 01600291 | Ø = 1,8 cm H = 0,6 cm | 1 |


To date, more than 4.000 patients have been treated with MaioRegen, which is considered an effective and safe treatment.
A randomized controlled clinical trial (RCT) vs. microfracture (Level of Evidence 1) shows a statistical significant improvement in the clinical scores (IKDC Subjective, Tegner, KOOS, VAS) at 2 years follow-up.
MaioRegen has proven to be superior to microfracture in the following indications: deep osteochondral lesions, osteochondritis dissecans (OCD) and in the population of sport active patients.
Deep Osteochondral Lesions (Outerbridge Grade IV)
Statistically significant superiority of MaioRegen vs. Microfracture (+12.4 points in change from baseline for IKDC subjective score).
Osteochondritis Dissecans (OCD)
Superiority of 12 points in change from baseline of MaioRegen vs. Microfracture in IKDC Subjective score.
Sport Active Patients
Statistically significant superiority of MaioRegen vs. Microfracture (+16 points in change from baseline for IKDC subjective score).
Superiority of MaioRegen treatment in these populations provides clear indications for the treatment of osteochondral lesions with MaioRegen Prime.
Moreover, a pilot study with 27 patients shows the stability of clinical scores at 8 year of follow-up, in patients suffering from complex lesions treated with MaioRegen
Subjective IKDCX – 96 months follow-up
Tegner Score – 96 months follow-up

Sessa A. et Al: Treatment of Juvenile Knee Osteochondritis Dissecans with a Cell-Free Biomimetic Osteochondral Scaffold: Clinical andMRI Results at Mid-Term Follow-u. Cartilage (2020).
Martincic D. et Al: Autologous chondrocytes versus filtered bone marrow mesenchymal stem/stromal cells for knee cartilage repair—a prospective study. Int_Ortho (2020).
Veber M. et Al: Combination of Filtered Bone Marrow Aspirate and Biomimetic Scaffold for the Treatment of Knee Osteochondral Lesions: Cellular and Early Clinical Results of a Single Centre Case Series. Tissue _Eng_Regen Med (2020).
Guerin g et Al.: Repair of large condylar osteochondral defects of the knee by collagenscaffold. Minimum two-year outcomes. Ortho. & Trauma. (2020).
Sessa A. et Al: Cell-Free Biomimetic Osteochondral Scaffold Implantation Technique. JBJS (2019).
Sessa A. et Al.: Cell-Free Osteochondral Scaold for the Treatment of Focal Articular Cartilage Defects in Early Knee OA: 5 Years’ Follow-Up Results. JCM (2019).
Mrtincic D et Al.: Survival Rates of Various Autologous Chondrocyte Grafts and Concomitant Procedures. Prospective Single-Center Study over 18 Years. Cell transplantation (2019).
D’ambrosi R. et Al.: MaioRegen Osteochondral Substitute for the Treatment of Knee Defects: A systematic Review of the Literature. JCM (2019).
Gabusi E. et Al.: Cartilage and Bone Serum Biomarkers as Novel Tools for Monitoring Knee steochondritis Dissecans Treated with Osteochondral Scaffold. BRI (2018).
Condello V. et Al.: Use of a Biomimetic Scaffold for the Treatment of Osteochondral Lesions in Early Osteoarthritis. BMRI (2018).
Kaipel M. et Al.: Beneficial clinical effects but limited tissue quality following osteochondral repair with a cell-free multi-layered nano-composite scaffold in the talus. FAS (2016).
Perdisa F. et Al.: Treatment of Knee Osteochondritis Dissecans With a Cell-Free Biomimetic Osteochondral Scaffold. AJSM (2017).
Mathis D. et Al.: Good clinical results but moderate osseointegration and defect filling of a cell‑free multi‑layered nano‑composite scaffold for treatment of osteochondral lesions of the knee. KSSTA (2017).
Albano D. et Al.: Clinical and imaging outcome of osteochondral lesions of the talus treated
using autologous matrix-induced chondrogenesis technique with a biomimetic scaffold. BMCMD (2017).
Kon E. et al. A multilayer biomaterial for osteochondral regeneration shows superiority vs microfractures for the treatment of osteochondral lesions in a multicentre randomized trial at 2 years. Knee Surg Sports Traumatol Arthrosc (2017).
Perdisa F. et al. One-Step treatment for patellar cartilage defects with a cell-free osteochondral scaffold. A prospective clinical and MRI evaluation. Am J Sports Med (2017).
Berruto M. et al. Can a biomimetic osteochondral scaffold be a reliable alternative to prosthetic surgery in treating late-stage SPONK? Knee (2016).
Brix M. et al. Successful osteoconduction but limited cartilage tissue quality following osteochondral repair by a cell-free multilayered nano-composite scaffold at the knee. Int Orthop (2016).
Di Martino A. et al. Surgical treatment of early knee osteoarthritis with a cell-free osteochondral scaffold: results at 24 months of follow-up. Injury (2015).
Verdonk P. et al. Treatment of Osteochondral Lesions in the Knee with a Cell-Free Scaffold. Bone Joint J (2015).
Christensen BB. et al. Poor osteochondral repair by a biomimetic collagen scaffold: 1- to 3-year clinical and radiological follow-up. Knee Surg Sports Traumatol Arthrosc (2015).
Persiani P. et al. Osteochondritis dissecans of the lateral femoral condyle in a patient affected by osteogenesis imperfecta: a case report. J Pediatric Orthop (2015).
Delcogliano M. et al. Treatment of osteochondritis dissecans of the knee with a biomimetic scaffold. A prospective multicenter study. Joints (2014).
Kon E. et al. Tibial plateau lesions. Surface reconstruction with a biomimetic osteochondral scaffold: Results at 2 years of follow-up. Injury (2014).
Berruto M. et al. Treatment of Large Knee Osteochondral Lesions With a Biomimetic Scaffold: Results of a Multicenter Study of 49 Patients at 2-Year Follow-up. Am J Sports Med (2014).
Kon E. et al. A one-step treatment for chondral and osteochondral knee defects: clinical results of a biomimetic scaffold implantation at 2 years of follow-up. J Mater Sci Mater Med (2014).
Filardo G. et al. Fibrin glue improves osteochondral scaffold fixation: study on the human cadaveric knee exposed to continuous passive motion. Osteoarthr Cartil (2014).
Filardo G. et al. Osteochondral scaffold reconstruction for complex knee lesions: a comparative evaluation. Knee (2013).
Delcogliano M. et al. Use of innovative biomimetic scaffold in the treatment for large osteochondral lesions of the knee. Knee Surg Sports Traumatol Arthrosc (2013).
Kon E. et al. Clinical Results and MRI Evolution of a Nano-Composite Multilayered Biomaterial for Osteochondral Regeneration at 5 Years. Am J Sports Med (2013).
Filardo G. et al. Treatment of Knee Osteochondritis Dissecans With a Cell-Free Biomimetic Osteochondral Scaffold: Clinical and Imaging Evaluation at 2-Year Follow-up. Am J Sports Med (2013).
Marcacci M. et al. Unicompartmental osteoarthritis: an integrated biomechanical and biological approach as alternative to metal resurfacing. Knee Surg Sports Traumatol Arthrosc (2013).
Filardo G. et al. Midterm results of a combined biological and mechanical approach for the treatment of a complex knee lesion. Cartilage (2012).
Kon E. et al. How to Treat Osteochondritis Dissecans of the Knee: Surgical Techniques and New Trends: AAOS Exhibit Selection. J Bone Joint Surg Am (2012).
Kon E. et al. Novel Nano-composite Multilayered Biomaterial for Osteochondral Regeneration: A Pilot Clinical Trial. Am J Sports Med (2011).
Kon E. et al. A novel nano-composite multi-layered biomaterial for treatment of osteochondral lesions: technique note and an early stability pilot clinical trial. Injury (2010).
Kon E. et al. Novel nano-composite multi-layered biomaterial for the treatment of multifocal degenerative cartilage lesions. Knee Surg Sports Traumatol Arthrosc (2009).
BLUE ELAF MEDICAL W.L.L.
Office 162, Floor 16,
Era58, Road No 1701,
Manama, Kingdom of Bahrain.
